Belite Bio, Inc Debt Conversion, Converted Instrument, Amount
Belite Bio, Inc (BLTE) reported Debt Conversion, Converted Instrument, Amount of $2.01 million for the 12-month period ending 2020-12-31, per its 20-F filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-03-31
| Period end | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|
| 2020-12-31 | $2.01M 20-F · filed 2023-03-31 |